Strides Pharma Science Limited recalls Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Sh…
- Recall date
- February 17, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1029-2020
- FDA classification
- Class III
- Brand / firm
- Strides Pharma Science Limited
- Sold / distributed
- U.S.A. Nationwide
Why it was recalled
Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08
Get recall alerts
Free email alert whenever Strides Pharma Science Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Strides Pharma Science Limited